Citation 78128

ACHENBACH,H: BENIRSCHKE,M: TORRENEGRA,R:. (1997). ALKALOIDS AND OTHER COMPOUNDS FROM SEEDS OF TABERNAEMONTANA CYMOSA.. 45(2)

Citation Details

Title	ALKALOIDS AND OTHER COMPOUNDS FROM SEEDS OF TABERNAEMONTANA CYMOSA.
Authors	ACHENBACH,H: BENIRSCHKE,M: TORRENEGRA,R:
Year	1997
Volume	45
Issue	2

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Tabernaemontana cymosa (APOCYNACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	OCTADECA-9-12-DIENOIC ACID	None
2	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LUPEOL	None
3	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	OBTUSIFOLIOL	None
4	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	OBTUSIFOLIOL	INACTIVE
5	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	OBTUSIFOLIOL	INACTIVE
6	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	OBTUSIFOLIOL	INACTIVE
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	OBTUSIFOLIOL	INACTIVE
8	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OBTUSIFOLIOL	INACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CONDYLOCARPINE	None
10	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	VINCAMINE,16-EPI: 14-15-DEHYDRO:	None
11	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VINCAMINE,16-EPI: 14-15-DEHYDRO:	INACTIVE
12	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VINCAMINE,16-EPI: 14-15-DEHYDRO:	INACTIVE
13	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VINCAMINE,16-EPI: 14-15-DEHYDRO:	INACTIVE
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VINCAMINE,16-EPI: 14-15-DEHYDRO:	INACTIVE
15	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VINCAMINE,16-EPI: 14-15-DEHYDRO:	INACTIVE
16	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HEYNEANINE	None
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CORONARIDINE,10-HYDROXY:	None
18	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CORONARIDINE,10-HYDROXY:	INACTIVE
19	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CORONARIDINE,10-HYDROXY:	INACTIVE
20	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CORONARIDINE,10-HYDROXY:	INACTIVE
21	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CORONARIDINE,10-HYDROXY:	INACTIVE
22	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CORONARIDINE,10-HYDROXY:	INACTIVE
23	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TABERSONINE,3-OXO:	None
24	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STEMMADENINE	None
25	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TABERSONINE,3-OXO:	INACTIVE
26	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TABERSONINE,3-OXO:	INACTIVE
27	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TABERSONINE,3-OXO:	INACTIVE
28	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TABERSONINE,3-OXO:	INACTIVE
29	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TABERSONINE,3-OXO:	INACTIVE
30	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STEMMADENINE	INACTIVE
31	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STEMMADENINE	INACTIVE
32	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STEMMADENINE	INACTIVE
33	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STEMMADENINE	INACTIVE
34	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STEMMADENINE	ACTIVE
35	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	STEMMADENINE-N-OXIDE	None
36	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	TABERSONINE-N-OXIDE	None
37	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TABERSONINE-N-OXIDE	INACTIVE
38	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TABERSONINE-N-OXIDE	INACTIVE
39	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TABERSONINE-N-OXIDE	INACTIVE
40	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TABERSONINE-N-OXIDE	INACTIVE
41	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TABERSONINE-N-OXIDE	INACTIVE
42	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATACD SPECTRUM REPORTED FOR	ALSTONINE,TETRAHYDRO:	None
43	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	VOACRISTINE	None
44	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LYONIRESINOL,(+):	None
45	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	LARICIRESINOL,5-5'-DIMETHOXY-9-O-(BETA-D-GLUCOPYRANOSYL): (+):	None
46	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LARICIRESINOL,5-5'-DIMETHOXY-9-O-(BETA-D-GLUCOPYRANOSYL): (+):	INACTIVE
47	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LARICIRESINOL,5-5'-DIMETHOXY-9-O-(BETA-D-GLUCOPYRANOSYL): (+):	INACTIVE
48	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LARICIRESINOL,5-5'-DIMETHOXY-9-O-(BETA-D-GLUCOPYRANOSYL): (+):	INACTIVE
49	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LARICIRESINOL,5-5'-DIMETHOXY-9-O-(BETA-D-GLUCOPYRANOSYL): (+):	INACTIVE
50	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LARICIRESINOL,5-5'-DIMETHOXY-9-O-(BETA-D-GLUCOPYRANOSYL): (+):	INACTIVE
51	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	ALSTONINE,TETRAHYDRO: 9-(BETA-D-GLUCOPYRANOSYL-OXY):	None
52	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SITSIRIKINE,ISO:	None
53	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SITSIRIKINE,ISO:	INACTIVE
54	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SITSIRIKINE,ISO:	INACTIVE
55	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SITSIRIKINE,ISO:	INACTIVE
56	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SITSIRIKINE,ISO:	INACTIVE
57	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SITSIRIKINE,ISO:	INACTIVE
58	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LYONIRESINOL,3-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (+):	None
59	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LYONIRESINOL,3-O-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):	None
60	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LYONIRESINOL,3-O-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):	INACTIVE
61	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LYONIRESINOL,3-O-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):	INACTIVE
62	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LYONIRESINOL,3-O-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):	INACTIVE
63	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LYONIRESINOL,3-O-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):	INACTIVE
64	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LYONIRESINOL,3-O-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):	INACTIVE
65	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	LYONIRESINOL,2-ALPHA-O-(BETA-D-GLUCOPYRANOSYL): (-):	None
66	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LARICIRESINOL,ISO: 3-ALPHA-O-(BETA-D-GLUCOPYRANOSYL)-5'-METHOXY: (-):	None
67	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LARICIRESINOL,ISO: SECO: 8-8-DIMETHOXY-1-O-(BETA-D-GLUCOPYRANOSYL):	None
68	Not specified	ISOLATION AND IDENTIFICATION OFINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	SWEROSIDE	None
69	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SWEROSIDE	INACTIVE
70	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SWEROSIDE	INACTIVE
71	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SWEROSIDE	INACTIVE
72	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SWEROSIDE	INACTIVE
73	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SWEROSIDE	INACTIVE
74	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	GALLIC ACID,5-O-METHYL-3-O-(BETA-D-GLUCOPYRANOSYL):	None
75	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	VOACANGINE	None
76	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GALLIC ACID,5-O-METHYL-3-O-(BETA-D-GLUCOPYRANOSYL):	INACTIVE
77	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GALLIC ACID,5-O-METHYL-3-O-(BETA-D-GLUCOPYRANOSYL):	INACTIVE
78	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GALLIC ACID,5-O-METHYL-3-O-(BETA-D-GLUCOPYRANOSYL):	INACTIVE
79	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GALLIC ACID,5-O-METHYL-3-O-(BETA-D-GLUCOPYRANOSYL):	INACTIVE
80	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID,5-O-METHYL-3-O-(BETA-D-GLUCOPYRANOSYL):	ACTIVE
81	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACANGINE	INACTIVE
82	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACANGINE	INACTIVE
83	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACANGINE	INACTIVE
84	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACANGINE	INACTIVE
85	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VOACANGINE	ACTIVE
86	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CORONARIDINE	None
87	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CORONARIDINE	ACTIVE
88	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CORONARIDINE	ACTIVE
89	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CORONARIDINE	INACTIVE
90	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CORONARIDINE	INACTIVE
91	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CORONARIDINE	WEAK ACTIVITY
92	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	VOACANGINE,7-ALPHA-HYDROXY-INDOLENINE:	None
93	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACANGINE,7-ALPHA-HYDROXY-INDOLENINE:	ACTIVE
94	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACANGINE,7-ALPHA-HYDROXY-INDOLENINE:	ACTIVE
95	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACANGINE,7-ALPHA-HYDROXY-INDOLENINE:	INACTIVE
96	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACANGINE,7-ALPHA-HYDROXY-INDOLENINE:	INACTIVE
97	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VOACANGINE,7-ALPHA-HYDROXY-INDOLENINE:	ACTIVE
98	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TABERSONINE	None
99	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TABERSONINE	ACTIVE
100	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TABERSONINE	INACTIVE
101	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TABERSONINE	INACTIVE
102	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TABERSONINE	ACTIVE
103	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TABERSONINE	INACTIVE
104	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	VOACANGINE,3-OXO:	None
105	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACANGINE,3-OXO:	ACTIVE
106	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACANGINE,3-OXO:	INACTIVE
107	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACANGINE,3-OXO:	INACTIVE
108	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	VOACANGINE,3-OXO:	INACTIVE
109	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	VOACANGINE,3-OXO:	INACTIVE

Citation 78128

Citation Details

Summary

Organisms and Their Experiments (1)

Tabernaemontana cymosa (APOCYNACEAE)

Show SPARQL Queries (1)

Query 1